TL;DR
- •Wellbutrin (bupropion) is an NDRI affecting dopamine and norepinephrine. Zoloft (sertraline) is an SSRI affecting serotonin. Different mechanisms, different side-effect profiles.
- •Wellbutrin causes no sexual dysfunction and is weight-neutral or weight-loss — Zoloft typically causes both. This is the most common reason patients choose Wellbutrin.
- •Zoloft has stronger evidence in anxiety, PTSD, panic. Wellbutrin can sometimes WORSEN anxiety.
- •Wellbutrin lowers seizure threshold — contraindicated in seizure history, eating disorders, alcohol withdrawal.
- •Combination therapy (Wellbutrin + Zoloft) is common — complementary mechanisms often produce stronger results and offset each other's side effects.
- •For treatment-resistant cases where both have failed, ketamine's NMDA mechanism is the most distinct option.
Side by side
Wellbutrin
Bupropion
NDRI (norepinephrine-dopamine reuptake inhibitor)
What it treats
Major depression, SAD, Smoking cessation (Zyban), Off-label ADHD adjunct, fatigue
Mechanism
Blocks reuptake of dopamine and norepinephrine. Does NOT affect serotonin significantly — explains the different side-effect profile from SSRIs.
Strengths
- •No sexual dysfunction (vs 30-50% on SSRIs)
- •Weight-neutral or weight-loss
- •Some attention/focus benefit
- •Doubles as smoking-cessation aid
Limitations
- •Lowers seizure threshold — contraindications matter
- •Not first-line for anxiety; can worsen it
- •Can cause insomnia, dry mouth, agitation, tremor
- •No OCD, panic, or social anxiety indication
Zoloft
Sertraline
SSRI
What it treats
Major depression, PTSD, OCD, Panic, Social anxiety, PMDD
Mechanism
Blocks serotonin reuptake at SERT with mild dopamine inhibition at higher doses. Broadest FDA indication list of any SSRI.
Strengths
- •Strongest SSRI evidence in PTSD and anxiety
- •FDA-approved for pediatric OCD
- •Mild dopaminergic effect may help anhedonia
- •Most pregnancy data of any SSRI
Limitations
- •Sexual dysfunction (30-50%)
- •GI side effects initially
- •Possible weight gain
- •Titration needed
Which one for your situation?
If:
Depression only, no anxiety/OCD/PTSD
Verdict:
Either reasonable. Sexual/weight concerns → Wellbutrin. Broad coverage → Zoloft.
If:
Anxiety, panic, PTSD, OCD, social anxiety in the picture
Verdict:
Zoloft — Wellbutrin doesn't treat these
If:
You smoke and want to quit
Verdict:
Wellbutrin — doubles as smoking-cessation aid
If:
Sexual dysfunction or weight gain on current SSRI
Verdict:
Wellbutrin — most common SSRI escape hatch
If:
Seizure history, bulimia, or alcohol withdrawal
Verdict:
Zoloft — Wellbutrin contraindicated
If:
Partial response to one — want to keep what's working
Verdict:
Combination therapy: add Wellbutrin to Zoloft (or vice versa) — augments and offsets side effects
Where ketamine fits
For treatment-resistant depression after both SSRI and NDRI failures, ketamine's NMDA mechanism is mechanistically distinct from any reuptake inhibitor. Strongest evidence in the treatment-resistant subset.
Wellbutrin: 4-8 weeks. Zoloft: 4-8 weeks. Sublingual ketamine: hours.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is Wellbutrin an antidepressant?
Yes — Wellbutrin (bupropion) is FDA-approved for major depression. Different mechanism (dopamine + norepinephrine, not serotonin) is why side-effect profile differs from SSRIs.
Why switch from Zoloft to Wellbutrin?
Most common: sexual dysfunction that won't resolve, persistent weight gain, or "emotional blunting" where Zoloft suppresses both negative AND positive affect. Wellbutrin's dopamine/norepinephrine profile addresses these.
Can I take both together?
Yes — well-established augmentation strategy. Complementary receptor profiles often produce better outcomes than either alone, and Wellbutrin mitigates Zoloft's sexual side effects. Coordinate dosing for seizure-threshold management.
Will Wellbutrin help my anxiety?
Probably not — and could make it worse. Wellbutrin is activating; can amplify anxiety. For anxiety-dominant presentations, an SSRI like Zoloft or an SNRI is first-line.
Both failed — what now?
After failures of mechanistically distinct antidepressants (SSRI + NDRI), the technical criteria for treatment-resistant depression apply. Options: lithium/antipsychotic augmentation, TMS, or ketamine. Ketamine is the most distinct mechanistic option.
References
- Cipriani A et al. 2018, Lancet. Network meta-analysis ranked bupropion and sertraline in efficacy tiers comparable to other first-line antidepressants. PMID 29477251
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — including patients failing both SSRI and NDRI trials. PMID 23982301